Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Staying Put Despite Q2 Disappointment
Go back to Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Staying Put Despite Q2 Disappointment| Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) | Delayed: 12.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.78 | 52 Week High | $16.80 | |||
| Open | $12.78 | 52 Week Low | $8.64 | |||
| Day High | $12.78 | P/E | N/A | |||
| Day Low | $12.78 | EPS | $-1.75 | |||
| Volume | 1,179,540 | |||||
